Ethionamide
Based on 5 publication(s) in Google Scholar
Ethionamide (2-ethylthioisonicotinamide) is a second-line anti-tuberculosis antibiotic with antibacterial effect and oral activity.
For research use only. We do not sell to patients.
- Purity: 99.98%
- CAS No.: 536-33-4
- Formula: C8H10N2S
- Molecular Weight:166.25
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Ethionamide
MoreAll Antibiotic Isoforms
More
Biological Activity
Ethionamide strongly inhibits mycolic acid synthesis in BCG strain Mycobacterium bovis cells. For M. tuberculosis Canetti, Mycobacterium sp. strain CR21, and ATCC 23366, the MIC values are 0.5, 3, and 60 μg/ml, respectively[2].
Ethionamide (60 μg/ml, 0-120 min) concurrently increases unsaturated mycolic acids and decreases oxygenated mycolic acids in M. aurum ATCC 23366[2].
Ethionamide's S-oxidation is primarily catalyzed by FMOs, particularly in the liver and lung[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:M.aurum ATCC 23366
-
Concentration:60 μg/ml
-
Incubation Time:0, 20, 40, 60, 80, 100, 120 min
-
Result:Unsaturated mycolic acid increases, oxygenated mycolic acid decreases.
Pharmacokinetic parameters of ethionamide in mice[4]
| Sex | Tmax (h) | Cmax (μg/mL) |
| Male | 1 | 15.1±34.4 |
| Femal | 1±0.5 | 15.1±14.8 |